| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.993 | 0.001 | 0.993 | Alpha 2b adrenoreceptor antagonist | 0.737 0.003 DBMET00757 | ||
| 0.981 | 0.002 | 0.981 | Alpha 2a adrenoreceptor antagonist | 0.559 0.004 DBMET00757 | ||
| 0.957 | 0.001 | 0.957 | Alpha 2c adrenoreceptor antagonist | 0.626 0.003 DBMET00757 | ||
| 0.956 | 0.002 | 0.956 | Alpha 2 adrenoreceptor antagonist | 0.492 0.004 DBMET00757 | ||
| 0.91 | 0.002 | 0.91 | 5 Hydroxytryptamine 2B antagonist | 0.548 0.005 DBMET00757 | ||
| 0.902 | 0.002 | 0.902 | Dopamine D2 agonist | 0.614 0.003 DBMET00757 | ||
| 0.895 | 0.002 | 0.895 | 5 Hydroxytryptamine 2C antagonist | 0.393 0.005 DBMET00757 | ||
| 0.864 | 0.003 | 0.864 | Dopamine agonist | 0.707 0.004 DBMET00757 | ||
| 0.822 | 0 | 0.822 | Prolactin inhibitor | 0.58 0.001 DBMET00757 | ||
| 0.768 | 0.003 | 0.768 | Dopamine D2 antagonist | 0.329 0.009 DBMET00757 | ||
| 0.768 | 0.004 | 0.768 | 5 Hydroxytryptamine antagonist | 0.38 0.012 DBMET00757 | ||
| 0.762 | 0.002 | 0.762 | Dopamine D1 antagonist | 0.518 0.003 DBMET00757 | ||
| 0.741 | 0.003 | 0.741 | 5 Hydroxytryptamine 1 antagonist | 0.25 0.013 DBMET00757 | ||
| 0.729 | 0.004 | 0.729 | Dopamine antagonist | 0.351 0.009 DBMET00757 | ||
| 0.725 | 0.004 | 0.725 | Alpha adrenoreceptor antagonist | 0.331 0.013 DBMET00757 | ||
| 0.719 | 0.004 | 0.719 | 5 Hydroxytryptamine 2 antagonist | 0.39 0.01 DBMET00757 | ||
| 0.69 | 0.003 | 0.69 | 5 Hydroxytryptamine 1A antagonist | 0.247 0.011 DBMET00757 | ||
| 0.672 | 0.009 | 0.827 | 5 Hydroxytryptamine release stimulant | 0.827 0.003 DBMET00757 | DBMET00757 | |
| 0.628 | 0.004 | 0.628 | 5 Hydroxytryptamine 2A antagonist | 0.333 0.01 DBMET00757 | ||
| 0.607 | 0.003 | 0.607 | 5 Hydroxytryptamine 5A antagonist | 0.211 0.005 DBMET00757 | ||
| 0.589 | 0.003 | 0.589 | 5 Hydroxytryptamine 1D antagonist | 0.137 0.014 DBMET00757 | ||
| 0.574 | 0.001 | 0.574 | Prolactin release inhibitor | 0.364 0.001 DBMET00757 | ||
| 0.563 | 0.003 | 0.563 | Alpha 1d adrenoreceptor antagonist | 0.149 0.014 DBMET00757 | ||
| 0.553 | 0.003 | 0.553 | 5 Hydroxytryptamine 5 antagonist | 0.181 0.005 DBMET00757 | ||
| 0.514 | 0.004 | 0.514 | Dopamine D3 antagonist | 0.155 0.014 DBMET00757 | ||
| 0.506 | 0.004 | 0.516 | 5 Hydroxytryptamine 1F antagonist | 0.516 0.004 DBMET00757 | DBMET00757 | |
| 0.513 | 0.021 | 0.513 | Spasmolytic | 0.441 0.033 DBMET00757 | ||
| 0.5 | 0.009 | 0.536 | Sigma receptor agonist | 0.536 0.007 DBMET00757 | DBMET00757 | |
| 0.487 | 0.005 | 0.487 | Alpha 1a adrenoreceptor antagonist | 0.165 0.021 DBMET00757 | ||
| 0.49 | 0.012 | 0.49 | Psychostimulant | 0.435 0.018 DBMET00757 | ||
| 0.444 | 0.005 | 0.444 | Alpha 1 adrenoreceptor antagonist | 0.17 0.026 DBMET00757 | ||
| 0.385 | 0.008 | 0.385 | Cholinergic antagonist | 0.321 0.013 DBMET00757 | ||
| 0.374 | 0.009 | 0.374 | Acetylcholine antagonist | 0.312 0.013 DBMET00757 | ||
| 0.365 | 0.007 | 0.365 | 5 Hydroxytryptamine 1E antagonist | 0.349 0.01 DBMET00757 | ||
| 0.353 | 0.006 | 0.353 | 5 Hydroxytryptamine agonist | 0.251 0.01 DBMET00757 | ||
| 0.329 | 0.002 | 0.329 | 5 Hydroxytryptamine 2B agonist | 0.164 0.003 DBMET00757 | ||
| 0.316 | 0.005 | 0.316 | 5 Hydroxytryptamine 1B antagonist | 0.137 0.014 DBMET00757 | ||
| 0.294 | 0.014 | 0.294 | Antiadrenergic | 0.217 0.021 DBMET00757 | ||
| 0.373 | 0.096 | 0.587 | Analgesic | 0.587 0.029 DBMET00757 | DBMET00757 | |
| 0.288 | 0.014 | 0.288 | Adrenaline antagonist | 0.213 0.021 DBMET00757 | ||
| 0.263 | 0.008 | 0.263 | 5 Hydroxytryptamine 1 agonist | 0.189 0.012 DBMET00757 | ||
| 0.252 | 0.025 | 0.296 | Acetylcholine M1 receptor antagonist | 0.296 0.015 DBMET00757 | DBMET00757 | |
| 0.219 | 0.003 | 0.219 | 5 Hydroxytryptamine 1D agonist | 0.059 0.008 DBMET00757 | ||
| 0.21 | 0.009 | 0.317 | Opioid kappa receptor antagonist | 0.317 0.005 DBMET00757 | DBMET00757 | |
| 0.192 | 0.007 | 0.192 | Dopamine D4 agonist | 0.087 0.017 DBMET00757 | ||
| 0.197 | 0.013 | 0.307 | Acetylcholine nicotinic antagonist | 0.307 0.007 DBMET00757 | DBMET00757 | |
| 0.196 | 0.015 | 0.248 | Opioid antagonist | 0.248 0.008 DBMET00757 | DBMET00757 | |
| 0.185 | 0.004 | 0.185 | 5 Hydroxytryptamine 2 agonist | 0.081 0.015 DBMET00757 | ||
| 0.177 | 0.004 | 0.177 | Alpha 2d adrenoreceptor antagonist | 0.149 0.009 DBMET00757 | ||
| 0.179 | 0.017 | 0.179 | Alpha 1b adrenoreceptor antagonist | 0.111 0.032 DBMET00757 | ||
| 0.161 | 0.006 | 0.275 | Dopamine D5 antagonist | 0.275 0.004 DBMET00757 | DBMET00757 | |
| 0.162 | 0.015 | 0.21 | Opioid mu receptor antagonist | 0.21 0.008 DBMET00757 | DBMET00757 | |
| 0.155 | 0.015 | 0.172 | Alpha adrenoreceptor agonist | 0.172 0.012 DBMET00757 | DBMET00757 | |
| 0.148 | 0.018 | 0.162 | Dopamine D4 antagonist | 0.162 0.016 DBMET00757 | DBMET00757 | |
| 0.145 | 0.016 | 0.164 | Analgesic, opioid | 0.164 0.013 DBMET00757 | DBMET00757 | |
| 0.147 | 0.02 | 0.184 | Opioid delta receptor antagonist | 0.184 0.014 DBMET00757 | DBMET00757 | |
| 0.15 | 0.044 | 0.15 | Acetylcholine muscarinic antagonist | 0.116 0.072 DBMET00757 | ||
| 0.123 | 0.017 | 0.188 | Neuronal nicotinic receptor antagonist | 0.188 0.009 DBMET00757 | DBMET00757 | |
| 0.115 | 0.011 | 0.143 | Alpha 2 adrenoreceptor agonist | 0.143 0.007 DBMET00757 | DBMET00757 | |
| 0.108 | 0.006 | 0.108 | Dopamine D3 agonist | 0.07 0.011 DBMET00757 | ||
| 0.166 | 0.065 | 0.166 | Cholinergic | |||
| 0.195 | 0.097 | 0.308 | Cyclic AMP phosphodiesterase inhibitor | 0.308 0.039 DBMET00757 | DBMET00757 | |
| 0.134 | 0.04 | 0.142 | Nav1.1 sodium channel blocker | 0.142 0.036 DBMET00757 | DBMET00757 | |
| 0.098 | 0.004 | 0.129 | Dopamine autoreceptor agonist | 0.129 0.004 DBMET00757 | DBMET00757 | |
| 0.196 | 0.104 | 0.196 | Peptidyltransferase inhibitor | |||
| 0.194 | 0.109 | 0.212 | Vasodilator | 0.212 0.095 DBMET00757 | DBMET00757 | |
| 0.086 | 0.006 | 0.107 | 5 Hydroxytryptamine 3B antagonist | 0.107 0.004 DBMET00757 | DBMET00757 | |
| 0.101 | 0.026 | 0.108 | 5 Hydroxytryptamine uptake inhibitor | 0.108 0.024 DBMET00757 | DBMET00757 | |
| 0.092 | 0.018 | 0.126 | 5 Hydroxytryptamine 2A agonist | 0.126 0.008 DBMET00757 | DBMET00757 | |
| 0.098 | 0.026 | 0.098 | 5 Hydroxytryptamine 7 antagonist | 0.091 0.027 DBMET00757 | ||
| 0.076 | 0.014 | 0.076 | 5 Hydroxytryptamine 1B agonist | 0.059 0.028 DBMET00757 | ||
| 0.085 | 0.023 | 0.14 | Dopamine uptake inhibitor | 0.14 0.011 DBMET00757 | DBMET00757 | |
| 0.085 | 0.024 | 0.085 | Adrenaline uptake inhibitor | 0.081 0.026 DBMET00757 | ||
| 0.102 | 0.054 | 0.102 | Antihistaminic | |||
| 0.066 | 0.018 | 0.09 | Nicotinic receptor alpha4 subunit antagonist | 0.09 0.01 DBMET00757 | DBMET00757 | |
| 0.069 | 0.022 | 0.115 | 5 Hydroxytryptamine 1A agonist | 0.115 0.013 DBMET00757 | DBMET00757 | |
| 0.05 | 0.005 | 0.077 | Dopamine D1 agonist | 0.077 0.004 DBMET00757 | DBMET00757 | |
| 0.089 | 0.049 | 0.09 | Histamine H1 receptor antagonist | 0.09 0.048 DBMET00757 | DBMET00757 | |
| 0.119 | 0.079 | 0.119 | Acetylcholinesterase inhibitor | |||
| 0.092 | 0.053 | 0.092 | Acetylcholine agonist | |||
| 0.092 | 0.053 | 0.092 | Histamine antagonist | |||
| 0.064 | 0.026 | 0.096 | Sigma receptor antagonist | 0.096 0.017 DBMET00757 | DBMET00757 | |
| 0.062 | 0.024 | 0.083 | Dopamine transporter inhibitor | 0.083 0.016 DBMET00757 | DBMET00757 | |
| 0.062 | 0.028 | 0.079 | Opioid agonist | 0.079 0.019 DBMET00757 | DBMET00757 | |
| 0.057 | 0.027 | 0.086 | 5 Hydroxytryptamine 4 antagonist | 0.086 0.011 DBMET00757 | DBMET00757 | |
| 0.072 | 0.047 | 0.072 | CXC chemokine receptor antagonist | |||
| 0.081 | 0.056 | 0.098 | Acetylcholine nicotinic agonist | 0.098 0.039 DBMET00757 | DBMET00757 | |
| 0.037 | 0.016 | 0.049 | CXC chemokine 3 receptor antagonist | 0.049 0.01 DBMET00757 | DBMET00757 | |
| 0.058 | 0.037 | 0.072 | 5 Hydroxytryptamine 3 antagonist | 0.072 0.028 DBMET00757 | DBMET00757 | |
| 0.15 | 0.129 | 0.533 | Anticonvulsant | 0.533 0.01 DBMET00757 | DBMET00757 | |
| 0.063 | 0.042 | 0.063 | Acetylcholine M2 receptor antagonist | |||
| 0.125 | 0.106 | 0.246 | NOS3 expression enhancer | 0.246 0.027 DBMET00757 | DBMET00757 | |
| 0.039 | 0.021 | 0.064 | p53 inhibitor | 0.064 0.007 DBMET00757 | DBMET00757 | |
| 0.039 | 0.02 | 0.039 | Opioid delta receptor agonist | 0.039 0.02 DBMET00757 | ||
| 0.166 | 0.149 | 0.166 | DNA damaging | |||
| 0.047 | 0.031 | 0.078 | Opioid mu receptor agonist | 0.078 0.018 DBMET00757 | DBMET00757 | |
| 0.053 | 0.038 | 0.094 | Nicotinic receptor alpha7 subunit antagonist | 0.094 0.013 DBMET00757 | DBMET00757 | |
| 0.052 | 0.042 | 0.101 | Protein kinase C eta inhibitor | 0.101 0.017 DBMET00757 | DBMET00757 | |
| 0.042 | 0.034 | 0.076 | 5 Hydroxytryptamine 2C agonist | 0.076 0.012 DBMET00757 | DBMET00757 | |
| 0.035 | 0.03 | 0.058 | Somatostatin 1 antagonist | 0.058 0.016 DBMET00757 | DBMET00757 | |
| 0.026 | 0.021 | 0.034 | Somatostatin 2 antagonist | 0.034 0.019 DBMET00757 | DBMET00757 | |
| 0.076 | 0.074 | 0.076 | Ca(v)3.1 blocker | |||
| 0.038 | 0.037 | 0.079 | Opioid kappa receptor agonist | 0.079 0.013 DBMET00757 | DBMET00757 | |
| 0.07 | 0.081 | 0.116 | Antineoplastic alkaloid | 0.116 0.039 DBMET00757 | DBMET00757 | |
| 0.029 | 0.041 | 0.035 | Protein kinase C beta I inhibitor | 0.035 0.018 DBMET00757 | DBMET00757 | |
| 0.085 | 0.1 | 0.148 | Toll-Like receptor 4 antagonist | 0.148 0.022 DBMET00757 | DBMET00757 | |
| 0.009 | 0.029 | 0.015 | NMDA receptor phencyclidine site antagonist | 0.015 0.012 DBMET00757 | DBMET00757 | |
| 0.025 | 0.049 | 0.046 | Nicotinic receptor beta4 subunit antagonist | 0.046 0.018 DBMET00757 | DBMET00757 | |
| 0.039 | 0.074 | 0.071 | Alpha 1 adrenoreceptor agonist | 0.071 0.027 DBMET00757 | DBMET00757 | |
| 0.07 | 0.127 | 0.162 | Adenylate cyclase inhibitor | 0.162 0.037 DBMET00757 | DBMET00757 | |
| 0.164 | 0.222 | 0.415 | Vasodilator, peripheral | 0.415 0.051 DBMET00757 | DBMET00757 | |
| 0.048 | 0.106 | 0.153 | Nicotinic alpha4beta2 receptor antagonist | 0.153 0.007 DBMET00757 | DBMET00757 | |
| 0.068 | 0.132 | 0.079 | CC chemokine 5 receptor agonist | 0.079 0.068 DBMET00757 | DBMET00757 | |
| 0.11 | 0.179 | 0.185 | Antipruritic | 0.185 0.06 DBMET00757 | DBMET00757 | |
| 0.008 | 0.087 | 0.039 | Somatostatin 5 antagonist | 0.039 0.019 DBMET00757 | DBMET00757 | |
| 0.056 | 0.135 | 0.084 | Protein kinase C delta inhibitor | 0.084 0.071 DBMET00757 | DBMET00757 | |
| 0.019 | 0.099 | 0.045 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.045 0.034 DBMET00757 | DBMET00757 | |
| 0.092 | 0.18 | 0.153 | MAP3K9 inhibitor | 0.153 0.055 DBMET00757 | DBMET00757 | |
| 0.03 | 0.129 | 0.059 | 5 Hydroxytryptamine 3A antagonist | 0.059 0.058 DBMET00757 | DBMET00757 | |
| 0.015 | 0.133 | 0.112 | NMDA 2A receptor antagonist | 0.112 0.011 DBMET00757 | DBMET00757 | |
| 0.031 | 0.15 | 0.088 | Nicotinic alpha3beta2 receptor antagonist | 0.088 0.01 DBMET00757 | DBMET00757 | |
| 0.02 | 0.14 | 0.07 | Nicotinic receptor alpha3 subunit antagonist | 0.07 0.015 DBMET00757 | DBMET00757 | |
| 0.064 | 0.233 | 0.123 | Neurotrophic factor | 0.123 0.091 DBMET00757 | DBMET00757 | |
| 0.046 | 0.23 | 0.112 | GABA C receptor antagonist | 0.112 0.061 DBMET00757 | DBMET00757 | |
| 0.024 | 0.243 | 0.171 | NMDA receptor antagonist | 0.171 0.019 DBMET00757 | DBMET00757 | |
| 0.103 | 0.331 | 0.339 | Immunosuppressant | 0.339 0.093 DBMET00757 | DBMET00757 | |
| 0.068 | 0.301 | 0.14 | GABA C receptor rho-2 antagonist | 0.14 0.088 DBMET00757 | DBMET00757 | |
| 0.008 | 0.315 | 0.08 | NMDA 2C receptor antagonist | 0.08 0.025 DBMET00757 | DBMET00757 | |
| 0.032 | 0.344 | 0.108 | GABA C receptor rho-1 antagonist | 0.108 0.052 DBMET00757 | DBMET00757 | |
| 0.005 | 0.325 | 0.115 | NMDA 2 receptor antagonist | 0.115 0.025 DBMET00757 | DBMET00757 | |
| 0.064 | 0.422 | 0.171 | DNA synthesis inhibitor | 0.171 0.166 DBMET00757 | DBMET00757 | |
| 0.12 | 0.511 | 0.279 | Calcium channel L-type activator | 0.279 0.175 DBMET00757 | DBMET00757 | |
| 0.016 | 0.439 | 0.123 | Glutamate receptor antagonist | 0.123 0.071 DBMET00757 | DBMET00757 | |
| 0.061 | 0.509 | 0.219 | Antibacterial | 0.219 0.208 DBMET00757 | DBMET00757 | |
| 0.071 | 0.536 | 0.229 | GABA C receptor rho-3 antagonist | 0.229 0.174 DBMET00757 | DBMET00757 | |
| 0.076 | 0.579 | 0.184 | Tyrosine 3 hydroxylase inhibitor | 0.184 0.168 DBMET00757 | DBMET00757 | |
| 0.037 | 0.554 | 0.224 | Transcription factor NF kappa B inhibitor | 0.224 0.147 DBMET00757 | DBMET00757 | |
| 0.031 | 0.607 | 0.2 | Hypoxia-inducible factor 1 alpha inhibitor | 0.2 0.152 DBMET00757 | DBMET00757 | |
| 0.058 | 0.653 | 0.339 | Antiinflammatory | 0.339 0.181 DBMET00757 | DBMET00757 | |
| 0.051 | 0.709 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.136 0.088 DBMET00757 | DBMET00757 | |
| 0.003 | 0.668 | 0.041 | GABA uptake inhibitor | 0.041 0.025 DBMET00757 | DBMET00757 | |
| 0.01 | 0.759 | 0.038 | Glutamate (mGluR8) antagonist | 0.038 0.019 DBMET00757 | DBMET00757 | |
| 0.005 | 0.822 | 0.099 | GABA C receptor agonist | 0.099 0.068 DBMET00757 | DBMET00757 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |